Skip Navigation LinksHome > March 2014 - Volume 36 - Issue 2 > Familial Hemophagocytic Lymphohistiocytosis Type 3 Diagnosed...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318292bc7c
Online Articles: Clinical and Laboratory Observations

Familial Hemophagocytic Lymphohistiocytosis Type 3 Diagnosed at School Age: A Case Report

Manno, Emma C. MD; Salfa, Irene MD; Palma, Paolo MD, PhD; Bertaina, Alice MD; Lombardi, Alessandra MD; Moretta, Francesca MD; L. Coniglio, Maria BSc; Sieni, Elena MD; Aricò, Maurizio MD, PhD; Finocchi, Andrea MD, PhD

Collapse Box


Familial hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condition characterized by immune hyperactivation and clinical signs of extreme inflammation. We describe a 7-year-old male who presented with fever resistant to antibiotic therapy, pancytopenia, splenomegaly, hypertriglyceridemia, and hyperferritinemia. Bone marrow aspirate showed hemophagocytosis. Epstein-Barr virus genome was positive in blood. Functional screening showed reduced capacity of cytotoxic degranulation. Mutation analysis of the FHL-related genes revealed compound heterozygous for UNC13D mutations: c. 753+1G>T, and the novel c.544C>T (p.P182S). Patients with a clinical presentation of HLH, even if older than typically seen, should be screened for familial HLH by mutation analysis.

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.